Elizabeth W Kwong

US Patent:

20110237541, Sep 29, 2011

Filed:

Nov 23, 2009

Appl. No.:

13/131058

Inventors:

Sylvie Toulmond - Beaconsfield, CA
Elizabeth Kwong - Cranford NJ, US
Dwight MacDonald - L'lle Bizard, CA

International Classification:

A61K 31/165
A61K 31/724
A61P 9/12
A61P 9/10
A61P 9/00
A61N 1/30
A61M 37/00
A61M 5/00
A61M 5/30

US Classification:

514 58, 514620, 604 20, 604 22, 604272, 604 68

Abstract:

Dosage form of aliskiren, comprising a device for transdermal administration of aliskiren and aliskiren (including salts, prodrugs and metabolites thereof), optionally together with pharmaceutically acceptable carrier(s) to a human being or an animal in order to achieve a desired therapeutic effect. Use of a compound comprising aliskiren, optionally encompassing salts, prodrugs and metabolites thereof, and optionally together with pharmaceutically acceptable carrier(s), for the manufacture of a composition to be administered transdermally for achieving a desired therapeutic effect. Method for achieving a desired therapeutic effect by transdermal administration of a compound comprising aliskiren, optionally encompassing salts, prodrugs and metabolites thereof, and optionally together with pharmaceutically acceptable carrier(s).